Bone Biologics Corporation (BBLG) NASDAQ

1.22

-0.089(-6.80%)

Updated at February 12 04:00PM

Currency In USD

Valuation

Market Cap8.56M
Enterprise Value5.23M
P/E Ratio-0.55
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio0.36
Enterprise/Revenue0
Enterprise/EBITDA1.19

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.62
Return On Equity-0.83

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA107,161
Net Income-4.11M
Diluted EPS-4.83

Balance Sheet

Total Cash6.05M
Total Cash/Share3.37
Total Debt0
Total Debt/Equity0
Current Ratio19
Book Value Per Share3.35

Price History

52-Week Change-80.26
52-Week High7.5
52-Week Low1.2
Moving Average 50 Days1.7
Moving Average 200 Days2.72

Statistics

Average Volume315,005
Shares Outstanding1.8M
% Held by Institutions0.82

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:6
Last Split DateJune 10, 2025